Osteoarthritis is a condition where the cartilage within joints (particularly in the hands, knees, hips and lower back) wears down with time. The most common symptom of osteoarthritis is chronic pain in the affected joints.
Chronic pain affects approximately 20% of the population, with the incidence rising significantly in the elderly. There are very few drugs available for treatment of chronic pain, and some of these are not fully able to relieve pain, or they come with a number of undesirable side effects.
The medication in this study is designed to reduce the number of pain messages sent through the nervous system to the brain, thereby reducing the perception of pain. It is also hoped to be associated with fewer of the side-effects seen in current pain medications. At this phase of testing we are looking for healthy people so we can investigate how the body metabolises the medication. The data acquired from this research will then be used to determine whether the medication can be given to people with osteoarthritis.
This clinical trial has been approved by an independent ethics committee, and you will be reimbursed for your time.
Call us on 1800 243 733 to discuss your eligibility today!